Fgf-9 is required for angiogenesis and osteogenesis in long bone repair

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 26, 2010, Pages 11853-11858

  Behr, Björn ^a,b   Leucht, Philipp ^a   Longaker, Michael T ^a   Quarto, Natalina ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Regeneration; Tibia; Tissue

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CD31 ANTIGEN; COLLAGEN; FIBROBLAST GROWTH FACTOR 9; GROWTH FACTOR; OSTEOCALCIN; PROTEIN VEGA A; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; CELL PROLIFERATION; FRACTURE HEALING; IMMUNOHISTOCHEMISTRY; LONG BONE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

ANIMALS; ANTIGENS, CD31; BIOLOGICAL MARKERS; BONE REGENERATION; FEMALE; FIBROBLAST GROWTH FACTOR 9; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RECOMBINANT PROTEINS; TIBIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 77955411097     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1003317107     Document Type: Article

References (41)

1. Einhorn TA (1998) The cell and molecular biology of fracture healing. Clin Orthop Relat Res 46 (355, Suppl)S7-S21. (Pubitemid 28538514)
2. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA (2003) Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88:873-884.
3. Schindeler A, McDonald MM, Bokko P, Little DG (2008) Bone remodeling during fracture repair: The cellular picture. Semin Cell Dev Biol 19:459-466.
4. Eswarakumar VP, et al. (2002) The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129:3783-3793.
5. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921. (Pubitemid 26106860)
6. Montero A, et al. (2000) Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093. (Pubitemid 30217693)
7. Coffin JD, et al. (1995) Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell 6:1861-1873.
8. Ohbayashi N, et al. (2002) FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16:870-879. (Pubitemid 34280110)
9. Quarto N, Behr B, Li S, Longaker MT (2009) Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones. Cells Tissues Organs 190:158-169.
10. Ornitz DM, Itoh N (2001) Fibroblast growth factors. Genome Biol 2 (3):S3005.
11. Hung IH, Yu K, Lavine KJ, Ornitz DM (2007) FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev Biol 307:300-313. (Pubitemid 47001360)
12. Liu Z, Xu J, Colvin JS, Ornitz DM (2002) Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869. (Pubitemid 34280109)
13. Schmid GJ, Kobayashi C, Sandell LJ, Ornitz DM (2009) Fibroblast growth factor expression during skeletal fracture healing in mice. Dev Dyn 238:766-774.
14. Keramaris NC, Calori GM, Nikolaou VS, Schemitsch EH, Giannoudis PV (2008) Fracture vascularity and bone healing:Asystematic reviewof the role of VEGF. Injury 39 (Suppl 2): S45-S57.
15. Gerber HP, et al. (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628.
16. Street J, et al. (2000) Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res (378):224-237.
17. White AC, Lavine KJ, Ornitz DM (2007) FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network. Development 134: 3743-3752.
18. Vu TH, et al. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422.
19. Rowe NM, et al. (1999) Angiogenesis during mandibular distraction osteogenesis. Ann Plast Surg 42:470-475.
20. Street J, et al. (2002) Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661.
21. Midy V, Plouët J (1994) Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 199:380-386. (Pubitemid 24179960)
22. Geiger F, et al. (2005) Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20:2028-2035. (Pubitemid 41532788)
23. Jacobsen KA, et al. (2008) Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling. J Bone Miner Res 23:596-609.
24. Barleon B, et al. (1997) Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57:5421-5425. (Pubitemid 27516384)
25. Shen BQ, et al. (1998) Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273:29979-29985. (Pubitemid 28510016)
26. Prewett M, et al. (1999) Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 59:5209-5218.
27. Nagatoro T, Fujita K, Murata E, Akita M (2003) Angiogenesis and fibroblast growth factors (FGFs) in a three-dimensional collagen gel culture. Okajimas Folia Anat Jpn 80:7-14. (Pubitemid 38005207)
28. Seghezzi G, et al. (1998) Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673. (Pubitemid 28309179)
29. Mignatti P, Morimoto T, Rifkin DB (1992) Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151:81-93.
30. Moscatelli D, Quarto N (1989) Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: Reversal of morphological transformation and restoration of receptor number by suramin. J Cell Biol 109:2519-2527. (Pubitemid 19282635)
31. Peng H, et al. (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110:751-759.
32. Peng H, et al. (2005) VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20: 2017-2027. (Pubitemid 41532787)
33. Collin-Osdoby P, et al. (2002) Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res 17:1859-1871.
34. Engsig MT, et al. (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879-889.
35. Zelzer E, et al. (2002) Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129:1893-1904. (Pubitemid 34874204)
36. Tsuji K, et al. (2006) BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38:1424-1429. (Pubitemid 44837565)
37. Duvall CL, Taylor WR, Weiss D, Wojtowicz AM, Guldberg RE (2007) Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res 22:286-297. (Pubitemid 46167799)
38. Monfoulet L, et al. (2010) Bone sialoprotein, but not osteopontin, deficiency impairs the mineralization of regenerating bone during cortical defect healing. Bone 46:447-452.
39. Colvin JS, White AC, Pratt SJ, Ornitz DM (2001) Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128:2095-2106.
40. Minear S, Leucht P, Miller S, Helms JA (2010) rBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair. J Bone Miner Res 25:1196-1207.
41. Kim JB, et al. (2007) Bone regeneration is regulated by wnt signaling. J Bone Miner Res 22:1913-1923. (Pubitemid 351229308)